MELANIE GOODWIN: Open Payments
NPI 1902357858 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 15 payments from 11 companies in 2025. Trend: 2023 $1,258 · 2024 $592 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Hologic Sales and Service, LLC | 1 | $31 |
| Radius Health, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| TOLMAR, INC. | 1 | $17 |
Products named: CAPLYTA, Kerendia, APTIMA, LINZESS, QULIPTA, Auvelity, AIRSUPRA, GEMTESA.
Industry payments across FL — which companies pay providers there.
